SANOFI-AVENTIS (EPA:SAN)

BRIEF

published on 03/18/2026 at 07:05, 4 days 12 hours ago

Sanofi's Venglustat Earns Breakthrough Therapy Designation for Gaucher Disease Type 3

FDA Sanofi Breakthrough Therapy Venglustat Gaucher Disease
BRIEF

published on 03/18/2026 at 07:05, 4 days 12 hours ago

Sanofi: Breakthrough Therapy Designation for venglustat in the United States

FDA Sanofi Venglustat Medical Discovery Gaucher's Disease
BRIEF

published on 03/18/2026 at 07:05, 4 days 12 hours ago

Sanofi : Désignation de thérapie innovante pour le venglustat aux États-Unis

FDA Sanofi Venglustat Maladie De Gaucher Découverte Médicale
BRIEF

published on 03/18/2026 at 07:05, 4 days 12 hours ago

Le venglustat de Sanofi obtient la désignation de thérapie innovante pour la maladie de Gaucher de type 3

FDA Sanofi Thérapie Révolutionnaire Venglustat Maladie De Gaucher
PRESS RELEASE

published on 03/18/2026 at 07:00, 4 days 12 hours ago

Communiqué de presse : Le venglustat de Sanofi a reçu la désignation de thérapie innovante aux États-Unis pour la maladie de Gaucher de type 3
Sanofi's venglustat receives innovative therapy designation in the US for Gaucher disease type 3. Positive results from the LEAP2MONO study reinforce its potential as a treatment option

FDA Sanofi Innovative Therapy Venglustat Gaucher Disease
PRESS RELEASE

published on 03/18/2026 at 07:00, 4 days 12 hours ago

Press Release: Sanofi’s venglustat earns Breakthrough Therapy designation in the US for type 3 Gaucher disease
Sanofi's venglustat receives Breakthrough Therapy designation in the US for type 3 Gaucher disease, a rare lysosomal storage disorder. Positive results from the LEAP2MONO study show significant improvements in neurological symptoms

Sanofi Breakthrough Therapy Venglustat Gaucher Disease Neurological Symptoms
BRIEF

published on 03/05/2026 at 09:21, 17 days 10 hours ago

Sanofi nomme Christel Heydemann administratrice indépendante

Gouvernance D'Entreprise Nomination Au Conseil D'administration Sanofi Diversité Christel Heydemann
BRIEF

published on 03/05/2026 at 09:21, 17 days 10 hours ago

Sanofi Nominates Christel Heydemann as Independent Director

Corporate Governance Board Appointment Diversity Sanofi Christel Heydemann
BRIEF

published on 03/05/2026 at 09:21, 17 days 10 hours ago

Sanofi: proposal to appoint Christel Heydemann as an independent director

Board Of Directors Appointment Diversity Sanofi Christel Heydemann
BRIEF

published on 03/05/2026 at 09:21, 17 days 10 hours ago

Sanofi : proposition de nomination de Christel Heydemann comme administratrice indépendante

Conseil D'administration Nomination Sanofi Diversité Christel Heydemann

Published on 03/20/2026 at 23:00, 1 day 20 hours ago

Cypher Announces Private Placement
Published on 03/20/2026 at 21:30, 1 day 22 hours ago

Sky Gold Sets Options
Published on 03/20/2026 at 21:15, 1 day 22 hours ago

Earthwise Minerals Announces Private Placement
Published on 03/20/2026 at 13:30, 2 days 6 hours ago

Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 7 hours ago

CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals

View all ACCESSWIRE

Published on 03/22/2026 at 18:22, 1 hour 8 minutes ago

Test news - please ignore EN
Published on 03/22/2026 at 12:23, 7 hours 7 minutes ago

Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 1 day 20 hours ago

Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 22 hours ago

Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 22 hours ago

Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion

View all EQS

Published on 03/20/2026 at 19:00, 2 days ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 1 hour ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 1 hour ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
Published on 03/20/2026 at 17:45, 2 days 1 hour ago

Cie du Bois Sauvage : Jaarverslag 2025

View all LES ECHOS COMFI WIRE

News